Trade

with

AstraZeneca PLC
(NYSE: AZN)
AdChoices
68.78
-0.22
-0.32%
Pre-Market :
69.22
+0.44
+0.64%

Open

68.90

Previous Close

69.00

Volume (Avg)

1.90M (2.47M)

Day's Range

68.76-69.61

52Wk Range

51.92-82.68

Market Cap.

87.13B

Dividend Rate (Yield )

2.80 (4.06%)

Beta

0.56

Shares Outstanding

1.26B

P/E Ratio (EPS)

42.92 (1.61)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 25.71B

    • Net Income

    • 2.56B

    • Market Cap.

    • 87.13B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 7.79

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.56

    • Forward P/E

    • 15.60

    • Price/Sales

    • 3.34

    • Price/Book Value

    • 3.94

    • Price/Cash flow

    • 12.47

      • EBITDA

      • 8.35B

      • Return on Capital %

      • 3.59

      • Return on Equity %

      • 8.94

      • Return on Assets %

      • 3.59

      • Book Value/Share

      • 17.45

      • Shares Outstanding

      • 1.26B

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.90 (8/13/2014)

      • Dividend Declaration Date

      • 7/31/2014

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 65.97

        • Credit Rating

        • AA-

        • Analysts

        • 6

        • EPS Estimate

        • 2.20

        • Cashflow Estimate

        • 5.96

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 3.60

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -59.40

          • 7.80

          • Net Income

            Q/Q (last year)

          • -3.30

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • -4.04

          • 6.10

          • Net Income

            5-Year Annual Average

          • -16.00

          • 3.73

          • Dividends

            5-Year Annual Average

          • 8.06

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 79.06

            • 69.92

            • Pre-Tax Margin

            • 9.17

            • 21.84

            • Net Profit Margin

            • 7.79

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • 81.10

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 28.60

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • 21.90

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.34

              • 0.32

              • Current Ratio

              • 0.99

              • 1.92

              • Quick Ratio

              • 0.85

              • 1.31

              • Interest Coverage

              • 4.28

              • 17.64

              • Leverage Ratio

              • 2.66

              • 2.03

              • Book Value/Share

              • 17.45

              • 14.72

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 42.37

                • 22.12

                • P/E Ratio 5-Year High

                • 51.50

                • 193.96

                • P/E Ratio 5-Year Low

                • 24.74

                • 87.26

                • Price/Sales Ratio

                • 3.30

                • 3.75

                • Price/Book Value

                • 3.90

                • 3.75

                • Price/Cash Flow Ratio

                • 12.47

                • 14.03

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 8.94

                    (31.70)

                  • 17.42

                    (18.66)

                  • Return on Assets %

                    (5-Year Average)

                  • 3.59

                    (12.80)

                  • 8.45

                    (8.77)

                  • Return on Capital %

                    (5-Year Average)

                  • 8.04

                    (25.50)

                  • 12.41

                    (13.18)

                  • Income/Employee

                  • 39.26k

                  • 90.07k

                  • Inventory Turnover

                  • 2.51

                  • 2.46

                  • Asset Turnover

                  • 0.46

                  • 0.46

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  3.71B
                  Operating Margin
                  14.44
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  12.47
                  Ownership

                  Institutional Ownership

                  8.24%

                  Top 10 Institutions

                  4.08%

                  Mutual Fund Ownership

                  3.26%

                  Float

                  -

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Wellington™

                  •  

                    10,379,730

                  • -12.95

                  • 0.82

                  • Vanguard Wellesley Income

                  •  

                    2,471,160

                  • 1.75

                  • 0.20

                  • Fidelity® Ser Intrinsic Opportunities Fd

                  •  

                    1,900,000

                  • -36.67

                  • 0.15

                  • Vanguard Windsor™ Fund

                  •  

                    1,722,300

                  • -17.19

                  • 0.14

                  • VA CollegeAmerica Cap Income Builder

                  •  

                    1,558,200

                  • 0.00

                  • 0.12

                  • Hartford Dividend and Growth Fund

                  •  

                    1,466,065

                  • 0.00

                  • 0.12

                  • Vanguard Equity Income Fund

                  •  

                    1,422,549

                  • 2.60

                  • 0.11

                  • Fidelity® Select Pharmaceuticals Port

                  •  

                    1,079,100

                  • -4.46

                  • 0.09

                  • Putnam Fund for Growth and Income Fund

                  •  

                    1,027,100

                  • 6.51

                  • 0.08

                  • Hartford Dividend and Growth HLS Fund

                  •  

                    796,175

                  • 0.00

                  • 0.06

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Wellington Management Company, LLP

                  •  

                    26,479,835

                  • -20.18%

                  • 2.10

                  • Fidelity Management and Research Company

                  •  

                    4,416,288

                  • -39.64%

                  • 0.35

                  • Arrowstreet Capital Limited Partnership

                  •  

                    3,174,970

                  • -28.90%

                  • 0.25

                  • Schafer Cullen Capital Management Inc

                  •  

                    2,393,638

                  • -36.77%

                  • 0.19

                  • Putnam Investment Management,LLC

                  •  

                    2,322,143

                  • -5.02%

                  • 0.18

                  • JANE STREET GROUP, LLC

                  •  

                    1,885,178

                  • +2,760.71%

                  • 0.15

                  • Renaissance Technologies Corp

                  •  

                    1,794,800

                  • +25.60%

                  • 0.14

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Major

                  Type

                  Classic Growth

                  Style

                  Large Core

                  AstraZeneca PLC was incorporated in England and Wales on 17 June 1992. From February 1993 until April 1999, the Company was called Zeneca Group PLC. On 6 April 1999, the Company changed its name to AstraZeneca PLC. It is a biopharmaceutical company. The Company focuses on three important areas of healthcare: Cardiovascular and Metabolic disease (CVMD); Oncology; and Respiratory, Inflammation and Autoimmunity (RIA). The Company is also engaged in the Infection, Neuroscience and Gastrointestinal (ING) disease areas. It operates in more than 100 countries.

                  Key People

                  Pascal Soriot

                  CEO/Director

                  Mr. Leif Johansson

                  Chairman of the Board/Director

                  Marc Dunoyer

                  CFO/Director/Executive VP, Divisional

                  Mr David Nicholas Smith

                  Executive VP, Divisional

                  Mr. Paul Hudson

                  Executive VP, Geographical

                  • AstraZeneca PLC

                  • 2 Kingdom Street

                  • London, W2 6BD

                  • GBR.Map

                  • Phone: +44 2076048000

                  • Fax: -

                  • astrazeneca.com

                  Incorporated

                  1992

                  Employees

                  51,500

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: